申请人:Alfa Farmaceutici, S.p.A.
公开号:US04246201A1
公开(公告)日:1981-01-20
Compound of formula: ##STR1## wherein R represents hydrogen or an alkyl group having from 1 to 4 carbon atoms; R', R", R'" and R"", equal or different from each other represent hydrogen atoms or OH groups, with the limitation that when R', R", R'" and R"" are all hydrogen atoms R cannot be an hydrogen atom and their salts with organic and inorganic pharmaceutically acceptable salts. The process for the preparation of the compounds of the above general formula are disclosed. The compounds show a good pharmacological activity and can be used as antiulcer, antispastic spasmolytic drugs. The compounds can be administered as different pharmaceutical preparations containing an effective dose of the compound in combination or in admixture with excipients suitable for oral or parenteral administration or for topical use.
化合物的化学式为:##STR1## 其中R代表氢或碳原子数为1至4的烷基基团;R',R",R'"和R""相等或不同,分别代表氢原子或羟基,但当R',R",R'"和R""均为氢原子时,R不能为氢原子,且它们与有机和无机药用可接受的盐的盐。公式所述化合物的制备方法已经公开。这些化合物具有良好的药理活性,可用作抗溃疡,抗痉挛药物。这些化合物可以作为不同的药物制剂,含有化合物的有效剂量,与适用于口服或注射或局部使用的赋形剂混合或组合使用。